A compound shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold

Researchers at UBC’s Life Sciences Institute have identified a compound that shows potential for early thwarting of infections by a variety of coronaviruses, including all variants of SARS-CoV-2 and the common cold. The findings, published this week in Molecular Biomedicine,…








